Minneapolis
89°F
eEdition
News & Politics
Sports
Food & Culture
Business
Outdoors
Opinion
Things To Do
Obituaries
More of What Matters to Minnesota
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Minnesota State Top Stocks
Markets
Minnesota Stocks
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Myriad Genetics Inc
(NQ:
MYGN
)
28.01
+0.35 (+1.27%)
Streaming Delayed Price
Updated: 1:42 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Myriad Genetics Inc
< Previous
1
2
3
4
5
6
7
Next >
Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
November 07, 2023
Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spectrum disorder Phase 2 study results in the Annals of General Psychiatry.
Via
Benzinga
Datadog, Tripadvisor, Myriad Genetics, Planet Fitness And Other Big Stocks Moving Higher On Tuesday
November 07, 2023
U.S. stocks traded mostly higher, with the Nasdaq Composite gaining around 50 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Earnings Scheduled For November 6, 2023
November 06, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million.
Via
Benzinga
Earnings Outlook For Myriad Genetics
November 03, 2023
Via
Benzinga
Myriad Genetics Reports Third Quarter 2023 Financial Results; Generates Double-Digit Revenue Growth; Raises 2023 Revenue Guidance and Introduces 2024 Revenue Guidance
November 06, 2023
From
Myriad Genetics, Inc.
Via
GlobeNewswire
Myriad Genetics Appoints Sam Raha as Chief Operating Officer
November 01, 2023
From
Myriad Genetics, Inc.
Via
GlobeNewswire
Myriad Genetics to Release Third Quarter Financial Results on November 6, 2023
October 31, 2023
From
Myriad Genetics, Inc.
Via
GlobeNewswire
Earnings Scheduled For August 3, 2023
August 03, 2023
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.
Via
Benzinga
Preview: Myriad Genetics's Earnings
August 02, 2023
Via
Benzinga
QIAGEN and Myriad Genetics partner to advance companion diagnostics development for cancer
October 26, 2023
From
Myriad Genetics, Inc.
Via
GlobeNewswire
Biotech Companies Make Further Progress in Promising Pancreatic Cancer Treatment Research
October 20, 2023
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:BNTX),(NASDAQ:SGEN),(NASDAQ:MYGN),(NASDAQ:ILMN) EQNX::TICKER_END
Via
FinancialNewsMedia
Exposures
Product Safety
New Myriad Genetics Survey Shows Breast Cancer Risk Factors Are Misunderstood
September 28, 2023
From
Myriad Genetics, Inc.
Via
GlobeNewswire
Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials
September 19, 2023
Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only test
From
Myriad Genetics, Inc.
Via
GlobeNewswire
Myriad Genetics Issues 2022 Environmental, Social and Governance Report
September 19, 2023
From
Myriad Genetics, Inc.
Via
GlobeNewswire
Myriad Genetics and Leading Cancer Center Collaborate to Study the Use of Minimal Residual Disease Testing in Breast Cancer
September 18, 2023
Research will use Myriad’s high-definition MRD testing platform based on whole-genome sequencing
From
Myriad Genetics, Inc.
Via
GlobeNewswire
Myriad Genetics Named to 2023 Best Workplaces in Health Care List by Fortune and Great Place To Work
September 06, 2023
From
Myriad Genetics, Inc.
Via
GlobeNewswire
New Myriad Genetics Survey Reveals Widespread Confusion and Misconceptions About Ovarian Cancer Screening Among a Majority of Women
September 06, 2023
Nearly three out of four women falsely believe a pap smear will reveal ovarian cancer presence
From
Myriad Genetics, Inc.
Via
GlobeNewswire
Myriad Genetics to Participate in Morgan Stanley Global Healthcare Conference
September 05, 2023
Myriad to also host Investor Day in South San Francisco in September
From
Myriad Genetics, Inc.
Via
GlobeNewswire
Myriad Genetics and Onsite Women’s Health Partner to Help More Women Understand Breast Cancer Risk
August 22, 2023
New collaboration increases access to genetic testing and can help identify patients with a high-risk for breast cancer
From
Myriad Genetics, Inc.
Via
GlobeNewswire
Myriad Genetics to Host Investor Day on September 19, 2023
August 17, 2023
From
Myriad Genetics, Inc.
Via
GlobeNewswire
Myriad Genetics Advances Prostate Cancer Care with Addition of Absolute Risk Reduction to Prolaris®
August 15, 2023
From
Myriad Genetics, Inc.
Via
GlobeNewswire
Intermountain Health and Myriad Genetics Participate in ComboMATCH
August 10, 2023
About Intermountain Health Headquartered in Utah with locations in seven states and additional operations across the western U.S., www.intermountainhealth.org is a nonprofit system of 33 hospitals, 385...
Via
PRUnderground
Myriad Genetics and Intermountain Health Participate in ComboMATCH, a National Clinical Trial to Advance Cancer Treatment
August 08, 2023
ComboMATCH study uses genetic testing to match advanced cancer patients with targeted treatments
From
Myriad Genetics, Inc.
Via
GlobeNewswire
Myriad Genetics Announces Enhancements to the GeneSight® Test to Personalize Mental Health Medication Treatment Decisions Based on Smoking Status
August 07, 2023
From
Myriad Genetics, Inc.
Via
GlobeNewswire
Myriad Genetics Reports Second Quarter 2023 Financial Results and Reaffirms 2023 Revenue and Adjusted EPS Guidance; Generates the Fourth Consecutive Quarter of Double-Digit Year-Over-Year Testing Volume Growth
August 03, 2023
From
Myriad Genetics, Inc.
Via
GlobeNewswire
Myriad Genetics to Release Second Quarter Financial Results on Aug. 3, 2023
July 27, 2023
From
Myriad Genetics, Inc.
Via
GlobeNewswire
Myriad Genetics Announces Inclusion of Breast Density to MyRisk® with RiskScore® Breast Cancer Risk Assessment
July 24, 2023
From
Myriad Genetics, Inc.
Via
GlobeNewswire
Myriad Genetics Announces New $90 Million Asset-Based Credit Facility
July 06, 2023
From
Myriad Genetics, Inc.
Via
GlobeNewswire
Cramer Calls Tech Giant A 'Great' Long-Term Play, But In The Short Term It's Just 'Too Hot'
June 22, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer said British American Tobacco p.l.c. (NYSE: BTI) is a "cheap stock. I’ll tell you, I actually like some of the things that Philip Morris International...
Via
Benzinga
3 Gene Testing Stocks to Buy Before They Take Off
June 17, 2023
The future of gene testing is bright thanks to an aging population. Here are three companies leading the industry.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.